European Respiratory Society Annual Congress 2013 Abstract Number: 1891 Publication Number: P494 Abstract Group: 4.3. Pulmonary Circulation and Pulmonary Vascular Disease Keyword 1: Pulmonary hypertension Keyword 2: Hypoxia Keyword 3: Animal models Title: Siah2 in pulmonary hypertension and right ventricular hypertrophy Daniela 12847 Haag
[email protected] 1, Dr. Dorothea M. 12848 Peters
[email protected] 1, Dr. Bakytbek 12849 Kojonazarov
[email protected] MD 1, Simone 12850 Kraut
[email protected] 1, Prof. Dr Hossein A. 12851 Ghofrani
[email protected] MD 1, Prof. Dr Ralph T. 12867 Schermuly
[email protected] 1, Prof. Dr Werner 14728 Seeger
[email protected] MD 1, Prof. Dr Friedrich 14730 Grimminger
[email protected] MD 1, Dr. Andreas 14737 Möller
[email protected] 3, Prof. Dr M. Lienhard 14745 Schmitz
[email protected] 2 and Prof. Dr Norbert 14775 Weissmann
[email protected] 1. 1 Excellence Cluster Cardio Pulmonary System ECCPS, Universities of Giessen and Marburg Lung Center UGMLC, Member of the Deutsches Zentrum Für Lungenforschung DZL, Justus-Liebig University Giessen, Giessen, Hesse, Germany, 35390 ; 2 Institute of Biochemistry, Justus-Liebig University Giessen, Giessen, Hesse, Germany, 35390 and 3 Head Tumour Microenvironment Laboratory, Queensland Institute of Medical Research, Herston, Brisbane, Queensland, Australia, 4006 . Body: Pulmonary hypertension (PH) is a disease of multifactorial etiology, which has a poor prognosis. It results in right heart hypertrophy which can culminate in decompensation and death.